Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
Editor-in-Chief: Professor Shein-Chung Chow
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (599)
- Volume 20, 2026 (12)
- Volume 19, 2025 (56)
- Volume 18, 2024 (35)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Latest articles:
- 5 records -
Optimization of Recombinant Human Interferon-Gamma Expression and Purification in E. coli, and Developing an Immunization Protocol for the Production of Optimal Humoral Response
Uwituze V, Mugasa CM, Namayanja M, Nalumenya DP, Ndayisenga J, Ssekatawa K, Kato CD
Biologics: Targets and Therapy 2026, 20:584180
Published Date: 16 April 2026
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori–Associated Ulcer Disease
Paulraj RS, Perumal P, Ramachandran A, Sathiyaseelan A
Biologics: Targets and Therapy 2026, 20:597797
Published Date: 14 April 2026
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk
Egba SI, Orhonigbe IO, Achi NK, Ikechukwu GC, Chukwu CN, Omeoga CH
Biologics: Targets and Therapy 2026, 20:603345
Published Date: 13 April 2026
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Elimam N, Albarari SS, Shaalan Y, Elsheikh SM, Alzamari AA, Elmekkawi N, Mogahed R, Alghuweiri RH
Biologics: Targets and Therapy 2026, 20:593367
Published Date: 31 March 2026
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
Garmish O, Smiyan S, Komorovsky R, Bilozetskyi I
Biologics: Targets and Therapy 2026, 20:588071
Published Date: 16 March 2026